Low T3 syndrome is associated with peripheral neuropathy in patients with type 2 diabetes mellitus

• Published in: Muscle & nerve Vol. 66; no. 6; pp. 723 - 729
• Main Authors: He, Weilei, Pang, Chunyang, Chen, Luowei, Zeng, Yaying, Gao, Lingfei, Huang, Huanjie, Zhang, Wanli, Wang, Xun, Deng, Binbin
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.12.2022; Wiley Subscription Services, Inc
• Subjects: Complications; Diabetes; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - complications; Diabetic Neuropathies - complications; Diabetic Neuropathies - etiology; diabetic peripheral neuropathy; Euthyroid Sick Syndromes - complications; Glycated Hemoglobin; Hemoglobin; Humans; low T3 syndrome; Nerve conduction; nerve conduction study; Patients; Peripheral neuropathy; severity; Thyroid; Thyroid gland; Thyroid hormones; Triiodothyronine; type 2 diabetes mellitus; low T3 syndrome; severity; nerve conduction study; type 2 diabetes mellitus; diabetic peripheral neuropathy
• ISSN: 0148-639X; 1097-4598
• DOI: 10.1002/mus.27719

Introduction/Aims Diabetic peripheral neuropathy (DPN) is one of the most common chronic complications of diabetes mellitus. Diabetic patients often have thyroid dysfunction. The aim of this study was to investigate the association between low triiodothyronine (T3) syndrome and DPN in patients with type 2 diabetes mellitus (T2DM). Methods A retrospective review was performed of 928 patients with T2DM for whom data was available for clinical manifestations and nerve conduction studies (NCS), and of 134 non‐diabetic controls. The composite Z scores of conduction velocity and amplitude were calculated. Low T3 syndrome was defined as T3 levels below the lower limit of the reference interval. Results Among the patients with T2DM, 632 (68.1%) had DPN, and a larger proportion of these patients presented with low T3 syndrome than patients without DPN. After adjusting for potential confounders, low T3 syndrome was independently associated with the occurrence of DPN (odds ratio [OR] = 2.049, 95% confidence interval [CI] 1.319–3.181, p = .001) and the severity of DPN (OR = 1.597, 95% CI 1.030–2.476, p = .036). Adding the criterion of low T3 syndrome improved the prognostic performance of the traditional model (age + gender + diabetic duration + glycated hemoglobin [HbA1c]) for predicting DPN. Discussion Low T3 syndrome is associated with a higher risk and increased severity of DPN in patients with T2DM. These findings suggest that low T3 syndrome could be a predictor for risk stratification in patients with T2DM.